Table 4.
SNP | GWAS Meta-Analysis | Replication | Combined | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ID | Chr | Pos (HG18) | Gene(s)a | Allele | PGWAS | OR | MAF | Prep. | OR (95% CI) | MAF | Poverall | Cochran Q | |||
Major | Minor | Case | Control | Case | Control | P | |||||||||
rs7543174a | 1q21 | 151,340,745 | IL6R | T | C | 7.9E-05 | 1.13 | 0.18 | 0.16 | 0.01 | 1.07 (1.01,1.13) | 0.19 | 0.18 | 1.2E-05 | 0.06 |
| |||||||||||||||
rs840016a | 1q24 | 164,140,328 | CD247 | C | T | 3.6E-05 | 0.90 | 0.39 | 0.42 | 0.006 | 0.92 (0.86,0.98) | 0.38 | 0.40 | 1.6E-06 | 0.62 |
| |||||||||||||||
rs13119723b | 4q27 | 123,575,918 | IL2, IL21† | A | G | 0.001 | 0.89 | 0.13 | 0.15 | 6.7E-05 | 0.87 (0.81,0.93) | 0.15 | 0.17 | 6.8E-07 | 0.46 |
| |||||||||||||||
rs11594656b | 10p15 | 6,162,015 | IL2RA† | T | A | 0.0002 | 0.90 | 0.23 | 0.25 | 0.04 | 0.95 (0.90,1.00) | 0.24 | 0.25 | 0.0001 | 0.86 |
| |||||||||||||||
rs2793108b | 10p11 | 31,419,111 | ZEB1 | T | C | 0.002 | 0.93 | 0.40 | 0.43 | 0.001 | 0.93 (0.89,0.98) | 0.41 | 0.43 | 1.4E-05 | 0.73 |
| |||||||||||||||
rs3184504b | 12q24 | 110,347,328 | SH2B3 | T | C | 0.004 | 0.93 | 0.49 | 0.49 | 0.0002 | 0.92 (0.88,0.96) | 0.48 | 0.49 | 6.0E-06 | 0.08 |
| |||||||||||||||
rs7155603a | 14q24 | 75,030,289 | BATF† | A | G | 1.0E-05 | 1.16 | 0.21 | 0.19 | 0.001 | 1.12 (1.04,1.20) | 0.23 | 0.21 | 1.1E-07 | 0.74 |
| |||||||||||||||
rs8045689a | 16p11 | 28,895,770 | CD19, NFATC2IP† | T | C | 5.3E-05 | 1.14 | 0.32 | 0.30 | 0.01 | 1.06 (1.01,1.12) | 0.32 | 0.30 | 2.4E-05 | 0.35 |
| |||||||||||||||
rs2872507b | 17q12 | 35,294,289 | IKZF3† | G | A | 4.7E-05 | 1.10 | 0.49 | 0.47 | 0.002 | 1.08 (1.02,1.14) | 0.48 | 0.46 | 9.4E-07 | 0.69 |
| |||||||||||||||
rs11203203b | 21q22 | 42,709,255 | UBASH3A† | G | A | 2.5E-05 | 1.11 | 0.39 | 0.37 | 0.02 | 1.07 (1.00,1.14) | 0.38 | 0.37 | 3.8E-06 | 0.49 |
| |||||||||||||||
rs5754217b | 22q11 | 20,264,229 | UBE2L3 | G | T | 0.0007 | 1.10 | 0.22 | 0.19 | 0.01 | 1.07 (1.01,1.13) | 0.22 | 0.21 | 4.8E-05 | 0.79 |
GWAS, replication and combined meta-analysis results for SNPs with highly suggestive associations with RA risk (defined as P<0.05 in our replication samples). As in Table 2, listed for each SNP are the rs ID, chromosomal location and position, candidate gene(s), and major and minor alleles, GWAS and replication analysis P-value, odds ratio and case/control minor allele frequencies, and the combined analysis P-values for association and for Cochran’s Q test for heterogeneity.
: Selected for replication based on GRAIL Ptext score
: Selected for replication based on PGWAS < 0.01 and validated autoimmune disease association: rs13119723, IL2/IL21, RA and Celiac; rs11594656, IL2RA, T1D and MS; rs2793108, ZEB1, T1D; rs3184504, SH2B3, Celiac and T1D; rs2872507, IKZF3, Crohn’s; rs11203203, UBASH3A, T1D; rs5754217, UBE2L3, SLE; the ZEB1 SNP was from the May 2009 release of the online T1D database (www.T1Dbase.org).
Autoimmune disease associations for SNPs other than those tested for replication in the present study (see text, Fig. 2 and Supplementary Note): CD247, Crohn’s; IL2/IL21, Celiac, RA and T1D; IL2RA, MS, RA and T1D; BATF, T1D; CD19/NFATC2IP, T1D; IKZF3, T1D; UBASH3A, Crohn’s and T1.